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Oligodendrocytes, the myelin-forming cells in the brain, are severely affected by ischemia [1], contributing to stroke-
associated deficits. The possibility to implement spontaneous post-injury repair mechanisms by targeting myelin still 
represents an unexplored field. In this respect, GPR17, a P2Y-like receptor transiently expressed on Oligodendrocyte 
Progenitor Cells (OPCs) has emerged as a target to implement stroke repair through stimulation of OPC maturation [2]. 
Results obtained by fate-mapping analysis using the conditional GPR17-iCreERT2xCAG-eGFP transgenic mice 
showed that the subpopulation of adult OPCs expressing GPR17 (GFP+-cells) represents “a reserve pool” that is 
maintained for repair purposes after brain damage [3]. In particular, we recently demonstrated that, after brain ischemia, 
GFP+-cells actively respond to injury increasing their proliferation rate and migratory capacity. However, at later stages, 
only a low percentage of these cells undergoes maturation [4]. This limited post-stroke repair is likely due to local 
unfavourable inflammatory milieu mediated by macrophages and resident microglia, which participate to post-ischemic 
inflammation assuming both detrimental and beneficial phenotypes.  
Here, we aimed at: (i) characterizing the spatio-temporal distribution of GFP+-cells in relation to microglia/macrophage 
polarization in transgenic mice after middle cerebral artery occlusion (MCAo); (ii) exploring the cross-talk between 
microglia and OPCs, by assessing how vesicles released extracellularly (EVs) by microglia, polarized toward a pro- or 
anti- inflammatory state, influence OPC behaviour.  
In vivo studies showed that GFP+-cells accumulate at the border of the ischemic lesion starting from 72h after ischemia, 
when microglia and macrophages show both pro- and anti-inflammatory features. One week after stroke, the absolute 
number of pro-inflammatory cells increases, while myeloid cells with pro-regenerative phenotype do not significantly 
change. In vitro studies pointed out that EVs produced by pro-inflammatory microglia only slightly limit OPC 
proliferation, whereas EVs produced by pro-reparative microglia tend to increase it. Preliminary data showed that all 
types of EVs (from unstimulated, pro-inflammatory or pro-regenerative microglia) are able to induce OPC migration, 
indicating that EVs provide attractive guidance cues independently of the activation state of donor microglia. 
Interestingly, EVs from pro-regenerative microglia have a higher chemotactic effect on the subpopulation of cells 
expressing GPR17, suggesting that EVs may also contain purinergic signals able to influence OPC migration via 
GPR17. Finally, exposure to EVs from either pro- or anti-inflammatory microglia (but not resting cells) promote OPC 
maturation. However, only EVs released by pro-regenerative cells significantly foster myelin deposition in an in vitro 
system of OPCs co-cultured with DRG neurons.  
Shedding light on these signals is important for developing combined therapeutic interventions where a purinergic 
approach, aimed at implementing recovery after stroke, is potentiated by agents promoting a better microglia phenotype 
with pro-regenerative effects on OPCs.  
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